Investment Summary |
|
|---|---|
| Date | 2022-04-18 |
| Target | Syft |
| Sector | Test/Measurement Equipment |
| Investor(s) | Ampersand Capital Partners |
| Deal Type | Growth Capital |
SEARCH BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 1988 |
| PE ASSETS | 3.0B USD |
| Size | Large |
| Type | Sector Focused |
Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 69 of 86 |
| Sector: Test/Measurement Equipment M&A | 2 of 2 |
| Type: Growth Capital M&A Deals | 21 of 25 |
| Country: New Zealand M&A | 2 of 2 |
| Year: 2022 M&A | 4 of 11 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-03-17 |
vivitide
Gardner, Massachusetts, United States vivitide is a provider of custom peptide synthesis services, custom antibodies, catalog peptides, and biochemicals to academia, pharmaceutical, biotech, and diagnostic companies worldwide. vivitide was founded in 1998 and is based in Gardner, Massachusetts. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-04-21 |
ALPCO
Salem, New Hampshire, United States ALPCO is an importer and distributor of immunoassay-based products for the North American life science markets. ALPCO is a provider of proprietary and distributed diagnostics solutions, with over 60 collaborating partners from around the globe. ALPCO was founded in 1990 and is based in Salem, New Hampshire. |
Sell | - |
